| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin G | 66 | 2024 | 4527 | 6.110 |
Why?
|
| In Situ Hybridization | 18 | 2021 | 1885 | 4.690 |
Why?
|
| Autoimmune Diseases | 41 | 2023 | 2223 | 4.530 |
Why?
|
| Pancreatic Neoplasms | 80 | 2024 | 5442 | 4.230 |
Why?
|
| Carcinoma, Pancreatic Ductal | 39 | 2024 | 1758 | 3.520 |
Why?
|
| Bile Duct Neoplasms | 19 | 2022 | 625 | 3.500 |
Why?
|
| Cholangiocarcinoma | 19 | 2022 | 578 | 3.310 |
Why?
|
| Plasma Cells | 29 | 2021 | 591 | 3.150 |
Why?
|
| Pancreatitis | 17 | 2023 | 1087 | 2.440 |
Why?
|
| Adenocarcinoma | 34 | 2024 | 6356 | 2.370 |
Why?
|
| Cholangitis, Sclerosing | 7 | 2023 | 177 | 2.370 |
Why?
|
| Colonic Neoplasms | 15 | 2024 | 2531 | 2.290 |
Why?
|
| Pancreatitis, Chronic | 11 | 2019 | 282 | 2.230 |
Why?
|
| Barrett Esophagus | 8 | 2024 | 494 | 2.190 |
Why?
|
| Pancreas | 18 | 2021 | 1698 | 2.040 |
Why?
|
| Diagnosis, Differential | 65 | 2023 | 12949 | 2.010 |
Why?
|
| Esophageal Neoplasms | 13 | 2024 | 1661 | 1.970 |
Why?
|
| Bone Neoplasms | 16 | 2023 | 2564 | 1.910 |
Why?
|
| Immunohistochemistry | 53 | 2024 | 11007 | 1.860 |
Why?
|
| Colonic Polyps | 5 | 2023 | 557 | 1.660 |
Why?
|
| Liver Neoplasms | 18 | 2023 | 4352 | 1.470 |
Why?
|
| Carcinoma | 7 | 2023 | 2309 | 1.440 |
Why?
|
| Sialadenitis | 4 | 2012 | 45 | 1.410 |
Why?
|
| Sarcoma | 10 | 2022 | 1801 | 1.370 |
Why?
|
| Granuloma, Plasma Cell | 3 | 2021 | 80 | 1.370 |
Why?
|
| Albumins | 3 | 2019 | 577 | 1.350 |
Why?
|
| Biopsy | 32 | 2024 | 6754 | 1.330 |
Why?
|
| Soft Tissue Neoplasms | 9 | 2022 | 1163 | 1.250 |
Why?
|
| RANK Ligand | 2 | 2020 | 320 | 1.190 |
Why?
|
| Colorectal Neoplasms | 16 | 2024 | 6952 | 1.170 |
Why?
|
| Hashimoto Disease | 2 | 2024 | 109 | 1.170 |
Why?
|
| Neuroendocrine Tumors | 12 | 2022 | 654 | 1.150 |
Why?
|
| Giant Cell Tumor of Bone | 2 | 2019 | 119 | 1.060 |
Why?
|
| Carcinoma, Hepatocellular | 7 | 2021 | 2328 | 1.030 |
Why?
|
| Adenocarcinoma, Mucinous | 6 | 2022 | 518 | 1.020 |
Why?
|
| Adenoma | 6 | 2024 | 2152 | 1.020 |
Why?
|
| Tumor Microenvironment | 14 | 2024 | 3948 | 1.000 |
Why?
|
| Bile Ducts, Intrahepatic | 12 | 2022 | 307 | 0.980 |
Why?
|
| Middle Aged | 173 | 2024 | 222903 | 0.970 |
Why?
|
| Humans | 326 | 2024 | 765734 | 0.970 |
Why?
|
| Thyroiditis | 2 | 2024 | 85 | 0.940 |
Why?
|
| Aged | 149 | 2024 | 171050 | 0.940 |
Why?
|
| Isocitrate Dehydrogenase | 8 | 2022 | 954 | 0.940 |
Why?
|
| Pancreatic Cyst | 6 | 2012 | 372 | 0.910 |
Why?
|
| Gallbladder Neoplasms | 4 | 2015 | 189 | 0.890 |
Why?
|
| Male | 203 | 2024 | 363585 | 0.860 |
Why?
|
| Female | 206 | 2024 | 395961 | 0.860 |
Why?
|
| Stomach Neoplasms | 9 | 2024 | 1472 | 0.860 |
Why?
|
| Biopsy, Fine-Needle | 8 | 2015 | 1129 | 0.850 |
Why?
|
| Chordoma | 6 | 2021 | 343 | 0.840 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 2022 | 961 | 0.820 |
Why?
|
| Adult | 133 | 2024 | 222974 | 0.810 |
Why?
|
| RNA-Binding Protein EWS | 3 | 2019 | 211 | 0.810 |
Why?
|
| Predictive Value of Tests | 30 | 2022 | 15390 | 0.800 |
Why?
|
| Colon | 6 | 2020 | 1795 | 0.800 |
Why?
|
| Liposarcoma | 3 | 2020 | 288 | 0.790 |
Why?
|
| Osteosarcoma | 7 | 2020 | 909 | 0.780 |
Why?
|
| Mucins | 5 | 2022 | 566 | 0.760 |
Why?
|
| Serum Albumin | 2 | 2015 | 676 | 0.760 |
Why?
|
| Immune System Diseases | 4 | 2017 | 251 | 0.760 |
Why?
|
| Hepatitis | 2 | 2020 | 227 | 0.750 |
Why?
|
| Neoplasm Invasiveness | 15 | 2022 | 3595 | 0.750 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2023 | 360 | 0.750 |
Why?
|
| Liver Abscess | 1 | 2021 | 81 | 0.740 |
Why?
|
| Aged, 80 and over | 73 | 2024 | 59459 | 0.740 |
Why?
|
| Retroperitoneal Space | 3 | 2019 | 172 | 0.730 |
Why?
|
| Liver | 7 | 2021 | 7559 | 0.720 |
Why?
|
| Digestive System | 1 | 2022 | 244 | 0.720 |
Why?
|
| Tissue Array Analysis | 7 | 2024 | 544 | 0.720 |
Why?
|
| Neoadjuvant Therapy | 14 | 2022 | 2895 | 0.710 |
Why?
|
| Chondroblastoma | 1 | 2020 | 47 | 0.710 |
Why?
|
| Orbital Pseudotumor | 4 | 2015 | 40 | 0.710 |
Why?
|
| Pathology, Clinical | 2 | 2022 | 374 | 0.700 |
Why?
|
| Carcinoma, Papillary | 3 | 2024 | 782 | 0.700 |
Why?
|
| Prognosis | 52 | 2024 | 29899 | 0.700 |
Why?
|
| Digestive System Diseases | 1 | 2022 | 151 | 0.690 |
Why?
|
| Pancreatectomy | 13 | 2021 | 819 | 0.660 |
Why?
|
| Dacryocystitis | 3 | 2018 | 67 | 0.650 |
Why?
|
| Paraproteinemias | 5 | 2013 | 252 | 0.640 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2020 | 99 | 0.640 |
Why?
|
| Gastrointestinal Diseases | 2 | 2019 | 1203 | 0.630 |
Why?
|
| Strongylida Infections | 1 | 2018 | 48 | 0.610 |
Why?
|
| Mastoiditis | 2 | 2016 | 37 | 0.610 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 7 | 2024 | 1105 | 0.610 |
Why?
|
| Skull Neoplasms | 1 | 2019 | 173 | 0.600 |
Why?
|
| Young Adult | 47 | 2021 | 59852 | 0.600 |
Why?
|
| RNA, Viral | 4 | 2021 | 2865 | 0.590 |
Why?
|
| Facial Bones | 1 | 2019 | 208 | 0.590 |
Why?
|
| Interferons | 2 | 2022 | 714 | 0.580 |
Why?
|
| Lung | 5 | 2021 | 10031 | 0.580 |
Why?
|
| Hypertension, Portal | 1 | 2020 | 229 | 0.580 |
Why?
|
| DNA Contamination | 1 | 2017 | 18 | 0.580 |
Why?
|
| Crohn Disease | 3 | 2022 | 2283 | 0.570 |
Why?
|
| Fibrosis | 14 | 2020 | 2068 | 0.570 |
Why?
|
| Salivary Glands | 1 | 2019 | 231 | 0.570 |
Why?
|
| Glycine | 1 | 2021 | 672 | 0.570 |
Why?
|
| Cysts | 3 | 2021 | 683 | 0.560 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 77 | 0.550 |
Why?
|
| DNA Mismatch Repair | 4 | 2024 | 433 | 0.530 |
Why?
|
| Forkhead Transcription Factors | 6 | 2022 | 1624 | 0.530 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2020 | 2429 | 0.530 |
Why?
|
| Adenoma, Bile Duct | 1 | 2016 | 29 | 0.530 |
Why?
|
| Cell Differentiation | 14 | 2021 | 11641 | 0.530 |
Why?
|
| Embolism, Fat | 1 | 2016 | 46 | 0.530 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2022 | 751 | 0.530 |
Why?
|
| Fibroma | 1 | 2018 | 197 | 0.520 |
Why?
|
| Eosinophilic Esophagitis | 2 | 2018 | 206 | 0.520 |
Why?
|
| Phlebitis | 4 | 2024 | 34 | 0.510 |
Why?
|
| Gastrointestinal Tract | 4 | 2018 | 834 | 0.510 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 506 | 0.510 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2015 | 84 | 0.500 |
Why?
|
| Microsatellite Instability | 3 | 2020 | 728 | 0.490 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2016 | 121 | 0.490 |
Why?
|
| Hamartoma | 1 | 2017 | 233 | 0.490 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 3 | 2022 | 120 | 0.490 |
Why?
|
| Esophagitis, Peptic | 1 | 2016 | 77 | 0.480 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2015 | 172 | 0.480 |
Why?
|
| Pancreatic Diseases | 1 | 2017 | 353 | 0.480 |
Why?
|
| Insulinoma | 3 | 2012 | 121 | 0.480 |
Why?
|
| Checklist | 2 | 2020 | 847 | 0.480 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 7 | 2016 | 1761 | 0.470 |
Why?
|
| Liver Diseases | 3 | 2021 | 1303 | 0.470 |
Why?
|
| Pyrroles | 1 | 2021 | 1119 | 0.470 |
Why?
|
| RNA, Messenger | 9 | 2022 | 12769 | 0.460 |
Why?
|
| Neck | 4 | 2015 | 733 | 0.460 |
Why?
|
| Endosonography | 3 | 2009 | 626 | 0.460 |
Why?
|
| Colitis, Ulcerative | 3 | 2019 | 1915 | 0.450 |
Why?
|
| Immunosuppressive Agents | 5 | 2019 | 4207 | 0.450 |
Why?
|
| Tumor Suppressor Protein p53 | 11 | 2023 | 2941 | 0.450 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 9 | 2015 | 691 | 0.450 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2020 | 1241 | 0.440 |
Why?
|
| Fluorouracil | 9 | 2021 | 1648 | 0.440 |
Why?
|
| Adenocarcinoma, Papillary | 2 | 2012 | 86 | 0.440 |
Why?
|
| Antineoplastic Agents | 9 | 2021 | 13639 | 0.440 |
Why?
|
| Pituitary Gland | 1 | 2016 | 633 | 0.440 |
Why?
|
| Leucovorin | 7 | 2021 | 641 | 0.430 |
Why?
|
| Submandibular Gland | 3 | 2016 | 83 | 0.430 |
Why?
|
| Cell Nucleus | 5 | 2016 | 2862 | 0.420 |
Why?
|
| Neoplasm Recurrence, Local | 17 | 2023 | 9368 | 0.420 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 3651 | 0.410 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2013 | 39 | 0.410 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2013 | 61 | 0.410 |
Why?
|
| Cystadenoma | 1 | 2012 | 76 | 0.410 |
Why?
|
| Pyrimidines | 4 | 2022 | 3044 | 0.400 |
Why?
|
| Colitis | 3 | 2024 | 1239 | 0.400 |
Why?
|
| Cystadenocarcinoma, Papillary | 1 | 2012 | 56 | 0.390 |
Why?
|
| Glucocorticoids | 7 | 2020 | 2132 | 0.390 |
Why?
|
| Tuberous Sclerosis | 2 | 2018 | 1036 | 0.390 |
Why?
|
| Eosinophilia | 3 | 2018 | 555 | 0.390 |
Why?
|
| Gene Rearrangement | 5 | 2021 | 1143 | 0.390 |
Why?
|
| Abdominal Pain | 1 | 2018 | 1069 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2022 | 8603 | 0.390 |
Why?
|
| Biopsy, Needle | 8 | 2019 | 1617 | 0.390 |
Why?
|
| Pancreatic Pseudocyst | 2 | 2009 | 112 | 0.380 |
Why?
|
| Retrospective Studies | 50 | 2022 | 81457 | 0.380 |
Why?
|
| Lymph Nodes | 10 | 2023 | 3451 | 0.380 |
Why?
|
| Adolescent | 36 | 2021 | 88781 | 0.380 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2011 | 16 | 0.380 |
Why?
|
| Keratins | 2 | 2021 | 497 | 0.380 |
Why?
|
| Mutation | 21 | 2024 | 30184 | 0.380 |
Why?
|
| Rectal Neoplasms | 3 | 2022 | 1182 | 0.370 |
Why?
|
| Gastric Mucosa | 5 | 2017 | 601 | 0.370 |
Why?
|
| Receptors, Notch | 3 | 2019 | 752 | 0.370 |
Why?
|
| Chondrosarcoma | 3 | 2023 | 301 | 0.370 |
Why?
|
| Abdomen | 1 | 2017 | 1133 | 0.370 |
Why?
|
| B-Lymphocytes | 5 | 2020 | 4779 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2016 | 2839 | 0.370 |
Why?
|
| Proto-Oncogene Proteins B-raf | 4 | 2022 | 2051 | 0.360 |
Why?
|
| Cystadenoma, Serous | 2 | 2009 | 99 | 0.360 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 4 | 2022 | 220 | 0.360 |
Why?
|
| Orbital Diseases | 1 | 2012 | 178 | 0.350 |
Why?
|
| Pyrazoles | 1 | 2021 | 2031 | 0.350 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2019 | 3737 | 0.340 |
Why?
|
| Submandibular Gland Diseases | 1 | 2010 | 22 | 0.340 |
Why?
|
| Hyperplasia | 4 | 2023 | 1144 | 0.340 |
Why?
|
| Parotid Diseases | 1 | 2010 | 49 | 0.330 |
Why?
|
| Femur | 1 | 2016 | 1310 | 0.330 |
Why?
|
| Carcinoid Tumor | 1 | 2011 | 225 | 0.330 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2022 | 156 | 0.330 |
Why?
|
| Sjogren's Syndrome | 5 | 2012 | 239 | 0.330 |
Why?
|
| Hemangiosarcoma | 2 | 2020 | 211 | 0.330 |
Why?
|
| Puerperal Disorders | 1 | 2012 | 305 | 0.330 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 1959 | 0.330 |
Why?
|
| Neurilemmoma | 1 | 2015 | 522 | 0.330 |
Why?
|
| DNA | 4 | 2022 | 7200 | 0.320 |
Why?
|
| Appendiceal Neoplasms | 1 | 2011 | 155 | 0.320 |
Why?
|
| Incidental Findings | 3 | 2013 | 696 | 0.320 |
Why?
|
| Immune Evasion | 2 | 2024 | 377 | 0.320 |
Why?
|
| Head | 1 | 2015 | 925 | 0.320 |
Why?
|
| Lung Diseases | 2 | 2018 | 1940 | 0.320 |
Why?
|
| Pyridines | 1 | 2021 | 2889 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 23 | 2021 | 20667 | 0.310 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 943 | 0.310 |
Why?
|
| Stem Cells | 6 | 2022 | 3539 | 0.310 |
Why?
|
| Radiography | 9 | 2017 | 6917 | 0.310 |
Why?
|
| Osteitis Fibrosa Cystica | 1 | 2008 | 11 | 0.310 |
Why?
|
| Cholestasis | 2 | 2022 | 386 | 0.310 |
Why?
|
| Paranasal Sinuses | 1 | 2011 | 267 | 0.300 |
Why?
|
| Eosinophils | 4 | 2018 | 945 | 0.300 |
Why?
|
| Cholecystitis | 1 | 2009 | 181 | 0.300 |
Why?
|
| Cholangitis | 1 | 2009 | 110 | 0.300 |
Why?
|
| Thyroid Gland | 2 | 2012 | 1168 | 0.300 |
Why?
|
| Gastroesophageal Reflux | 1 | 2016 | 833 | 0.300 |
Why?
|
| Goblet Cells | 1 | 2011 | 301 | 0.300 |
Why?
|
| Inflammation | 6 | 2022 | 10846 | 0.290 |
Why?
|
| Repressor Proteins | 1 | 2019 | 2968 | 0.290 |
Why?
|
| Celiac Disease | 3 | 2022 | 820 | 0.290 |
Why?
|
| Cytomegalovirus Infections | 1 | 2014 | 835 | 0.290 |
Why?
|
| Notochord | 1 | 2007 | 37 | 0.290 |
Why?
|
| Treatment Outcome | 32 | 2024 | 65180 | 0.290 |
Why?
|
| Respiratory System | 1 | 2011 | 559 | 0.290 |
Why?
|
| Ilium | 1 | 2008 | 154 | 0.280 |
Why?
|
| Liver Function Tests | 2 | 2020 | 526 | 0.280 |
Why?
|
| Fibrosarcoma | 2 | 2023 | 313 | 0.280 |
Why?
|
| Hepatectomy | 5 | 2021 | 589 | 0.280 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2008 | 123 | 0.280 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2007 | 83 | 0.280 |
Why?
|
| Immune Complex Diseases | 1 | 2006 | 50 | 0.270 |
Why?
|
| Child | 27 | 2022 | 80499 | 0.270 |
Why?
|
| Recurrence | 10 | 2020 | 8498 | 0.270 |
Why?
|
| Pancreaticoduodenectomy | 6 | 2019 | 512 | 0.260 |
Why?
|
| Gastritis | 2 | 2019 | 200 | 0.260 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 10 | 2021 | 11865 | 0.260 |
Why?
|
| Histocompatibility Antigens Class I | 4 | 2024 | 1364 | 0.250 |
Why?
|
| Leiomyoma | 3 | 2023 | 643 | 0.250 |
Why?
|
| Antibodies, Monoclonal | 4 | 2021 | 9245 | 0.250 |
Why?
|
| Follow-Up Studies | 20 | 2021 | 39180 | 0.250 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2016 | 1416 | 0.250 |
Why?
|
| Colitis, Microscopic | 2 | 2019 | 72 | 0.250 |
Why?
|
| Sclerosis | 4 | 2015 | 211 | 0.250 |
Why?
|
| RNA | 6 | 2022 | 2717 | 0.250 |
Why?
|
| Disease-Free Survival | 13 | 2023 | 6832 | 0.250 |
Why?
|
| Intestines | 5 | 2022 | 1906 | 0.250 |
Why?
|
| Neoplasm Staging | 13 | 2023 | 11201 | 0.250 |
Why?
|
| Ovarian Neoplasms | 4 | 2023 | 4900 | 0.240 |
Why?
|
| Human papillomavirus 16 | 3 | 2016 | 268 | 0.240 |
Why?
|
| Hypoglycemia | 1 | 2012 | 896 | 0.240 |
Why?
|
| Esophagoscopy | 3 | 2020 | 398 | 0.240 |
Why?
|
| Esophagogastric Junction | 2 | 2024 | 351 | 0.240 |
Why?
|
| Intestinal Mucosa | 8 | 2022 | 3046 | 0.240 |
Why?
|
| Kaplan-Meier Estimate | 11 | 2024 | 6499 | 0.230 |
Why?
|
| SOXF Transcription Factors | 1 | 2024 | 31 | 0.230 |
Why?
|
| Lymphoma | 3 | 2017 | 1896 | 0.230 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2021 | 616 | 0.220 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 1349 | 0.220 |
Why?
|
| Sensitivity and Specificity | 14 | 2016 | 14637 | 0.220 |
Why?
|
| Epithelial Cells | 3 | 2020 | 3683 | 0.220 |
Why?
|
| Hypergammaglobulinemia | 3 | 2013 | 70 | 0.220 |
Why?
|
| beta 2-Microglobulin | 1 | 2024 | 330 | 0.220 |
Why?
|
| Gene Fusion | 3 | 2021 | 356 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7477 | 0.210 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2003 | 21 | 0.210 |
Why?
|
| Agrin | 2 | 2022 | 75 | 0.210 |
Why?
|
| Rheumatoid Nodule | 1 | 2003 | 15 | 0.210 |
Why?
|
| Long Interspersed Nucleotide Elements | 3 | 2023 | 332 | 0.210 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2019 | 539 | 0.210 |
Why?
|
| Pancreatic Ducts | 4 | 2021 | 331 | 0.210 |
Why?
|
| Lymphocytes | 4 | 2024 | 2600 | 0.210 |
Why?
|
| Papillomavirus Infections | 4 | 2022 | 1638 | 0.210 |
Why?
|
| Pericarditis, Constrictive | 1 | 2003 | 46 | 0.210 |
Why?
|
| Survival Rate | 13 | 2021 | 12787 | 0.210 |
Why?
|
| Immunologic Factors | 6 | 2016 | 1585 | 0.210 |
Why?
|
| Prednisone | 5 | 2018 | 1563 | 0.210 |
Why?
|
| RNA, Satellite | 1 | 2022 | 16 | 0.200 |
Why?
|
| Alkylating Agents | 1 | 2023 | 134 | 0.200 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2016 | 702 | 0.200 |
Why?
|
| Genes, Neoplasm | 2 | 2017 | 370 | 0.200 |
Why?
|
| Camptothecin | 2 | 2017 | 600 | 0.200 |
Why?
|
| Genes, ras | 4 | 2016 | 657 | 0.200 |
Why?
|
| Macrophages | 4 | 2020 | 5772 | 0.200 |
Why?
|
| Coloring Agents | 2 | 2023 | 562 | 0.200 |
Why?
|
| Sarcoma, Synovial | 1 | 2023 | 155 | 0.200 |
Why?
|
| Head and Neck Neoplasms | 4 | 2021 | 2918 | 0.200 |
Why?
|
| Granuloma | 2 | 2022 | 327 | 0.200 |
Why?
|
| Mikulicz' Disease | 2 | 2012 | 6 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2011 | 2878 | 0.200 |
Why?
|
| Disease Progression | 10 | 2024 | 13614 | 0.200 |
Why?
|
| Urologic Neoplasms | 1 | 2005 | 310 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2021 | 36537 | 0.190 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2022 | 222 | 0.190 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 200 | 0.190 |
Why?
|
| Intestinal Neoplasms | 3 | 2014 | 313 | 0.190 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2021 | 41 | 0.190 |
Why?
|
| Chemotherapy, Adjuvant | 5 | 2021 | 3537 | 0.190 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2023 | 2504 | 0.190 |
Why?
|
| Colitis, Ischemic | 1 | 2021 | 32 | 0.190 |
Why?
|
| Carcinoma, Verrucous | 1 | 2021 | 26 | 0.190 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2016 | 632 | 0.180 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2021 | 68 | 0.180 |
Why?
|
| Spinal Neoplasms | 1 | 2007 | 708 | 0.180 |
Why?
|
| Monitoring, Immunologic | 1 | 2021 | 99 | 0.180 |
Why?
|
| Cell Line, Tumor | 17 | 2022 | 17062 | 0.180 |
Why?
|
| Necrosis | 2 | 2022 | 1613 | 0.180 |
Why?
|
| Precancerous Conditions | 5 | 2017 | 974 | 0.180 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2015 | 4036 | 0.180 |
Why?
|
| Desmin | 3 | 2020 | 99 | 0.180 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2021 | 135 | 0.170 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2020 | 1127 | 0.170 |
Why?
|
| Signal Transduction | 9 | 2020 | 23589 | 0.170 |
Why?
|
| Enterocolitis | 1 | 2021 | 107 | 0.170 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 150 | 0.170 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2001 | 1426 | 0.170 |
Why?
|
| Oncogene Fusion | 1 | 2020 | 84 | 0.170 |
Why?
|
| Chronic Disease | 7 | 2019 | 9351 | 0.170 |
Why?
|
| Phenotype | 8 | 2022 | 16706 | 0.170 |
Why?
|
| Lymphocytosis | 2 | 2014 | 120 | 0.170 |
Why?
|
| Reproducibility of Results | 9 | 2021 | 20120 | 0.170 |
Why?
|
| Steroids | 2 | 2019 | 931 | 0.170 |
Why?
|
| Child, Preschool | 13 | 2020 | 42468 | 0.170 |
Why?
|
| Cell Dedifferentiation | 1 | 2020 | 125 | 0.170 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.160 |
Why?
|
| Ketone Bodies | 1 | 2019 | 75 | 0.160 |
Why?
|
| Dioxygenases | 1 | 2022 | 354 | 0.160 |
Why?
|
| Turkey | 1 | 2020 | 281 | 0.160 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2021 | 330 | 0.160 |
Why?
|
| Cadherins | 3 | 2016 | 900 | 0.160 |
Why?
|
| Epithelioid Cells | 2 | 2020 | 60 | 0.160 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2020 | 309 | 0.160 |
Why?
|
| Colonoscopy | 4 | 2020 | 1406 | 0.160 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 2 | 2009 | 101 | 0.160 |
Why?
|
| Leprosy, Borderline | 1 | 1998 | 4 | 0.160 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2005 | 788 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 4 | 2020 | 2036 | 0.160 |
Why?
|
| Neuritis | 1 | 1998 | 35 | 0.160 |
Why?
|
| Gene Expression Profiling | 6 | 2024 | 9522 | 0.160 |
Why?
|
| Hepatocytes | 2 | 2017 | 1246 | 0.150 |
Why?
|
| Immunophenotyping | 3 | 2015 | 1865 | 0.150 |
Why?
|
| Image Enhancement | 4 | 2001 | 2859 | 0.150 |
Why?
|
| Histiocytes | 3 | 2009 | 95 | 0.150 |
Why?
|
| Budesonide | 1 | 2019 | 163 | 0.150 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2019 | 133 | 0.150 |
Why?
|
| HLA Antigens | 2 | 2021 | 1338 | 0.150 |
Why?
|
| Histiocytosis, Sinus | 1 | 1998 | 44 | 0.150 |
Why?
|
| Gastrectomy | 2 | 2021 | 694 | 0.150 |
Why?
|
| Cytodiagnosis | 2 | 2015 | 450 | 0.150 |
Why?
|
| Neoplasms | 5 | 2023 | 22345 | 0.150 |
Why?
|
| Parasitic Diseases | 1 | 2018 | 76 | 0.150 |
Why?
|
| Pericardium | 1 | 2003 | 679 | 0.150 |
Why?
|
| Chi-Square Distribution | 4 | 2013 | 3432 | 0.150 |
Why?
|
| Human papillomavirus 18 | 2 | 2016 | 125 | 0.150 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2019 | 474 | 0.150 |
Why?
|
| Cyst Fluid | 2 | 2009 | 86 | 0.150 |
Why?
|
| Cohort Studies | 12 | 2020 | 41631 | 0.150 |
Why?
|
| Endoscopy | 1 | 2008 | 1849 | 0.150 |
Why?
|
| Treponema pallidum | 1 | 2018 | 48 | 0.150 |
Why?
|
| Synovial Cyst | 1 | 2018 | 33 | 0.150 |
Why?
|
| Immunity | 2 | 2021 | 1002 | 0.150 |
Why?
|
| Echo-Planar Imaging | 2 | 2001 | 649 | 0.150 |
Why?
|
| Smad4 Protein | 1 | 2019 | 193 | 0.140 |
Why?
|
| Receptors, Virus | 1 | 2021 | 651 | 0.140 |
Why?
|
| Automation, Laboratory | 2 | 2015 | 102 | 0.140 |
Why?
|
| Esophagectomy | 1 | 2021 | 477 | 0.140 |
Why?
|
| Fractures, Spontaneous | 1 | 2019 | 230 | 0.140 |
Why?
|
| Gastrinoma | 1 | 2017 | 20 | 0.140 |
Why?
|
| Intestinal Diseases | 2 | 2016 | 506 | 0.140 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2019 | 169 | 0.140 |
Why?
|
| Lymphadenitis | 1 | 1998 | 98 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2022 | 5693 | 0.140 |
Why?
|
| Rhabdoid Tumor | 1 | 2019 | 209 | 0.140 |
Why?
|
| DNA Mutational Analysis | 5 | 2020 | 4106 | 0.140 |
Why?
|
| Antibodies, Neoplasm | 1 | 2019 | 282 | 0.140 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 309 | 0.140 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2017 | 37 | 0.140 |
Why?
|
| Folate Receptor 1 | 1 | 2017 | 41 | 0.140 |
Why?
|
| Phenylurea Compounds | 2 | 2019 | 536 | 0.140 |
Why?
|
| Organoplatinum Compounds | 2 | 2017 | 404 | 0.140 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2014 | 340 | 0.140 |
Why?
|
| Autopsy | 1 | 2020 | 1011 | 0.140 |
Why?
|
| Spine | 2 | 2018 | 1129 | 0.140 |
Why?
|
| Diarrhea | 2 | 2014 | 1316 | 0.140 |
Why?
|
| Polyuria | 1 | 2016 | 37 | 0.140 |
Why?
|
| Angiotensins | 1 | 2017 | 139 | 0.130 |
Why?
|
| Postoperative Complications | 5 | 2016 | 15749 | 0.130 |
Why?
|
| Survival Analysis | 6 | 2020 | 10069 | 0.130 |
Why?
|
| Antirheumatic Agents | 3 | 2015 | 1363 | 0.130 |
Why?
|
| DNA, Neoplasm | 3 | 2012 | 1740 | 0.130 |
Why?
|
| Adenocarcinoma, Sebaceous | 1 | 2016 | 21 | 0.130 |
Why?
|
| Chromosome Aberrations | 3 | 2012 | 1774 | 0.130 |
Why?
|
| Mucous Membrane | 1 | 2019 | 656 | 0.130 |
Why?
|
| Sebaceous Gland Neoplasms | 1 | 2016 | 38 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2021 | 1831 | 0.130 |
Why?
|
| Deoxycytidine | 3 | 2019 | 889 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2020 | 5336 | 0.130 |
Why?
|
| Diabetes Insipidus | 1 | 2016 | 143 | 0.130 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2016 | 62 | 0.130 |
Why?
|
| Mitotic Index | 1 | 2016 | 158 | 0.130 |
Why?
|
| Terminology as Topic | 3 | 2012 | 1535 | 0.130 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2015 | 28 | 0.130 |
Why?
|
| Stomach Diseases | 1 | 2017 | 134 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2010 | 6427 | 0.130 |
Why?
|
| Interleukin-8 | 1 | 2019 | 700 | 0.120 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 1727 | 0.120 |
Why?
|
| Mice | 25 | 2024 | 81792 | 0.120 |
Why?
|
| Rectum | 1 | 2020 | 896 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 697 | 0.120 |
Why?
|
| Coronary Vessels | 3 | 2001 | 3097 | 0.120 |
Why?
|
| Glutarates | 2 | 2014 | 243 | 0.120 |
Why?
|
| Mouth | 1 | 2018 | 382 | 0.120 |
Why?
|
| Orbital Myositis | 2 | 2013 | 23 | 0.120 |
Why?
|
| Ligands | 1 | 2022 | 3273 | 0.120 |
Why?
|
| Syphilis | 1 | 2018 | 243 | 0.120 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 17 | 0.120 |
Why?
|
| Stomach | 1 | 2019 | 700 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 3 | 2019 | 871 | 0.120 |
Why?
|
| Radiography, Abdominal | 1 | 2018 | 544 | 0.120 |
Why?
|
| Azacitidine | 1 | 2017 | 334 | 0.120 |
Why?
|
| X Chromosome Inactivation | 1 | 2017 | 229 | 0.120 |
Why?
|
| Diplopia | 1 | 2016 | 217 | 0.120 |
Why?
|
| Anus Neoplasms | 1 | 2019 | 336 | 0.120 |
Why?
|
| Mastocytosis, Systemic | 1 | 2016 | 102 | 0.120 |
Why?
|
| Carcinoma in Situ | 3 | 2012 | 776 | 0.120 |
Why?
|
| Foreign Bodies | 2 | 2014 | 402 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1365 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2017 | 780 | 0.120 |
Why?
|
| Cell Proliferation | 8 | 2020 | 10428 | 0.120 |
Why?
|
| Lymph Node Excision | 2 | 2023 | 1259 | 0.120 |
Why?
|
| Granuloma, Lethal Midline | 1 | 2014 | 4 | 0.120 |
Why?
|
| DNA Methylation | 4 | 2017 | 4425 | 0.120 |
Why?
|
| Pain | 3 | 2016 | 5074 | 0.120 |
Why?
|
| Arginase | 1 | 2015 | 81 | 0.120 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 2 | 2013 | 180 | 0.110 |
Why?
|
| Biliary Tract Diseases | 1 | 2015 | 160 | 0.110 |
Why?
|
| DNA, Viral | 3 | 2016 | 2199 | 0.110 |
Why?
|
| Infant | 6 | 2019 | 36363 | 0.110 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2014 | 104 | 0.110 |
Why?
|
| Antibody-Producing Cells | 1 | 2014 | 138 | 0.110 |
Why?
|
| Placenta | 2 | 2020 | 1728 | 0.110 |
Why?
|
| Electric Power Supplies | 1 | 2014 | 94 | 0.110 |
Why?
|
| Neurofibromatosis 1 | 1 | 2019 | 560 | 0.110 |
Why?
|
| Spasm | 1 | 2014 | 131 | 0.110 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2014 | 23 | 0.110 |
Why?
|
| Uterine Neoplasms | 1 | 2023 | 1421 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2019 | 1608 | 0.110 |
Why?
|
| Lymphatic Metastasis | 5 | 2022 | 2882 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2014 | 126 | 0.110 |
Why?
|
| Intestine, Small | 2 | 2013 | 1214 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2020 | 3784 | 0.110 |
Why?
|
| Transcription Factors | 6 | 2019 | 12123 | 0.110 |
Why?
|
| Ethmoid Sinusitis | 1 | 2013 | 25 | 0.110 |
Why?
|
| Burns, Chemical | 1 | 2014 | 123 | 0.110 |
Why?
|
| Hepacivirus | 1 | 2001 | 1343 | 0.110 |
Why?
|
| Muscle, Smooth | 2 | 2019 | 931 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2022 | 4038 | 0.110 |
Why?
|
| Genotype | 4 | 2016 | 13024 | 0.110 |
Why?
|
| Gastroscopy | 2 | 2012 | 213 | 0.110 |
Why?
|
| England | 1 | 2015 | 533 | 0.110 |
Why?
|
| Animals | 31 | 2024 | 168731 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2019 | 1075 | 0.110 |
Why?
|
| Sirtuins | 1 | 2016 | 322 | 0.110 |
Why?
|
| Vasculitis | 1 | 2017 | 522 | 0.110 |
Why?
|
| Homeostasis | 3 | 2022 | 3336 | 0.110 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2013 | 31 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2014 | 647 | 0.110 |
Why?
|
| Helicobacter pylori | 1 | 2016 | 380 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2019 | 1112 | 0.100 |
Why?
|
| Helicobacter Infections | 1 | 2016 | 390 | 0.100 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 347 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 4 | 2015 | 7424 | 0.100 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2015 | 648 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 1999 | 0.100 |
Why?
|
| Germinal Center | 1 | 2015 | 379 | 0.100 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2016 | 279 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2022 | 4161 | 0.100 |
Why?
|
| Myofibroblasts | 1 | 2014 | 229 | 0.100 |
Why?
|
| Disease Models, Animal | 8 | 2017 | 18289 | 0.100 |
Why?
|
| Stress Fibers | 1 | 2012 | 55 | 0.100 |
Why?
|
| Femoral Fractures | 1 | 2016 | 375 | 0.100 |
Why?
|
| United States | 8 | 2021 | 72898 | 0.100 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2013 | 110 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2014 | 488 | 0.100 |
Why?
|
| Pleural Effusion | 1 | 2015 | 345 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2021 | 24279 | 0.100 |
Why?
|
| Lacrimal Apparatus | 2 | 2011 | 224 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 2454 | 0.100 |
Why?
|
| Carcinoembryonic Antigen | 2 | 2014 | 336 | 0.100 |
Why?
|
| Remission Induction | 4 | 2020 | 2409 | 0.100 |
Why?
|
| Osteoclasts | 1 | 2016 | 713 | 0.100 |
Why?
|
| Paneth Cells | 1 | 2012 | 99 | 0.100 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2013 | 169 | 0.100 |
Why?
|
| Fasting | 1 | 2018 | 1606 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5891 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 2021 | 2445 | 0.100 |
Why?
|
| Anal Canal | 2 | 2019 | 376 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 1610 | 0.090 |
Why?
|
| Meningitis | 1 | 2013 | 217 | 0.090 |
Why?
|
| Paresthesia | 1 | 2012 | 159 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 2 | 2016 | 553 | 0.090 |
Why?
|
| Drainage | 1 | 2017 | 1180 | 0.090 |
Why?
|
| Neoplasm Proteins | 3 | 2019 | 3593 | 0.090 |
Why?
|
| Cell Count | 3 | 2016 | 1823 | 0.090 |
Why?
|
| Viral Load | 1 | 2020 | 3385 | 0.090 |
Why?
|
| Ultrasonography | 3 | 2017 | 5986 | 0.090 |
Why?
|
| Thyroid Function Tests | 1 | 2012 | 289 | 0.090 |
Why?
|
| Tracheal Stenosis | 1 | 2013 | 227 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1747 | 0.090 |
Why?
|
| Heterocyclic Compounds | 3 | 2020 | 245 | 0.090 |
Why?
|
| F-Box Proteins | 1 | 2013 | 199 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2018 | 4136 | 0.090 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2011 | 47 | 0.090 |
Why?
|
| Embolism, Cholesterol | 1 | 2010 | 33 | 0.090 |
Why?
|
| DNA, Satellite | 1 | 2011 | 67 | 0.090 |
Why?
|
| Arthritis, Experimental | 1 | 2013 | 288 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2001 | 8926 | 0.090 |
Why?
|
| RNA, Neoplasm | 2 | 2011 | 745 | 0.090 |
Why?
|
| Maxillary Neoplasms | 1 | 2010 | 47 | 0.090 |
Why?
|
| Granulocytes | 1 | 2012 | 549 | 0.090 |
Why?
|
| Validation Studies as Topic | 1 | 2011 | 162 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4563 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2020 | 22224 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 1378 | 0.090 |
Why?
|
| Stromal Cells | 3 | 2021 | 1330 | 0.090 |
Why?
|
| Communication | 2 | 2023 | 3914 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2018 | 1806 | 0.090 |
Why?
|
| DNA-Binding Proteins | 4 | 2022 | 9594 | 0.090 |
Why?
|
| Chromatin | 3 | 2024 | 2981 | 0.080 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 1087 | 0.080 |
Why?
|
| beta Catenin | 2 | 2016 | 1042 | 0.080 |
Why?
|
| Sublingual Gland | 1 | 2009 | 11 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 3 | 2008 | 1696 | 0.080 |
Why?
|
| Fever | 1 | 2017 | 1602 | 0.080 |
Why?
|
| Lysosomes | 1 | 2015 | 932 | 0.080 |
Why?
|
| Cause of Death | 1 | 2020 | 3709 | 0.080 |
Why?
|
| Mandibular Neoplasms | 1 | 2010 | 131 | 0.080 |
Why?
|
| Bronchoscopy | 1 | 2015 | 909 | 0.080 |
Why?
|
| Carmine | 1 | 2009 | 4 | 0.080 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2012 | 214 | 0.080 |
Why?
|
| Alcian Blue | 1 | 2009 | 13 | 0.080 |
Why?
|
| Genomics | 2 | 2017 | 5924 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 772 | 0.080 |
Why?
|
| Hyperinsulinism | 1 | 2012 | 402 | 0.080 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2011 | 904 | 0.080 |
Why?
|
| Reference Values | 5 | 2019 | 4909 | 0.080 |
Why?
|
| Mice, SCID | 4 | 2019 | 2627 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3584 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 3794 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2015 | 1798 | 0.080 |
Why?
|
| Cecum | 1 | 2010 | 231 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 1424 | 0.080 |
Why?
|
| Polyps | 1 | 2011 | 200 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2822 | 0.080 |
Why?
|
| Aortitis | 1 | 2010 | 76 | 0.080 |
Why?
|
| Sacrum | 2 | 2008 | 270 | 0.080 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2009 | 62 | 0.080 |
Why?
|
| Nasal Cavity | 1 | 2011 | 309 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 1801 | 0.080 |
Why?
|
| Organometallic Compounds | 3 | 2020 | 644 | 0.080 |
Why?
|
| Histones | 2 | 2016 | 2592 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2001 | 2412 | 0.080 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2009 | 185 | 0.080 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 13448 | 0.080 |
Why?
|
| Jaundice | 1 | 2009 | 94 | 0.080 |
Why?
|
| Esophagus | 1 | 2014 | 1037 | 0.080 |
Why?
|
| Epigenesis, Genetic | 4 | 2017 | 3818 | 0.080 |
Why?
|
| Wound Healing | 1 | 2019 | 2790 | 0.080 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1554 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 1994 | 0.080 |
Why?
|
| Antigen-Antibody Complex | 2 | 2007 | 508 | 0.070 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2010 | 186 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 2185 | 0.070 |
Why?
|
| Ampulla of Vater | 1 | 2008 | 150 | 0.070 |
Why?
|
| Eye Diseases | 1 | 2013 | 659 | 0.070 |
Why?
|
| Coccyx | 1 | 2007 | 13 | 0.070 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2011 | 526 | 0.070 |
Why?
|
| Metformin | 1 | 2015 | 904 | 0.070 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2009 | 108 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2014 | 616 | 0.070 |
Why?
|
| Eating | 1 | 2014 | 1539 | 0.070 |
Why?
|
| Pathology, Surgical | 1 | 2009 | 146 | 0.070 |
Why?
|
| Integrins | 1 | 2012 | 839 | 0.070 |
Why?
|
| Appendectomy | 1 | 2011 | 444 | 0.070 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 949 | 0.070 |
Why?
|
| Intestinal Polyps | 1 | 2008 | 105 | 0.070 |
Why?
|
| Immunotherapy | 2 | 2021 | 4752 | 0.070 |
Why?
|
| Gallbladder | 1 | 2009 | 308 | 0.070 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2007 | 34 | 0.070 |
Why?
|
| Dihematoporphyrin Ether | 1 | 2007 | 33 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2003 | 3733 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1876 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2018 | 2097 | 0.070 |
Why?
|
| Autophagy | 1 | 2015 | 1352 | 0.070 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 453 | 0.070 |
Why?
|
| Combined Modality Therapy | 5 | 2022 | 8528 | 0.070 |
Why?
|
| North America | 2 | 2014 | 1285 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 1 | 2008 | 273 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 6061 | 0.070 |
Why?
|
| Thyroid Diseases | 1 | 2010 | 385 | 0.070 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2011 | 305 | 0.070 |
Why?
|
| Organ Transplantation | 1 | 2017 | 1174 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2011 | 1213 | 0.070 |
Why?
|
| Boston | 3 | 2020 | 9337 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2013 | 1505 | 0.070 |
Why?
|
| Cell Nucleolus | 1 | 2007 | 155 | 0.070 |
Why?
|
| Hypocalcemia | 1 | 2008 | 205 | 0.070 |
Why?
|
| Multiple Organ Failure | 1 | 2009 | 389 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 18061 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 345 | 0.070 |
Why?
|
| Nephritis, Interstitial | 1 | 2007 | 157 | 0.070 |
Why?
|
| src Homology Domains | 1 | 2007 | 361 | 0.060 |
Why?
|
| Risk Factors | 5 | 2024 | 74831 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4255 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 2427 | 0.060 |
Why?
|
| Pelvic Bones | 1 | 2008 | 273 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2010 | 893 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 2794 | 0.060 |
Why?
|
| Tuberculosis | 1 | 2018 | 2013 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2013 | 2194 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 1118 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2019 | 1336 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2012 | 1087 | 0.060 |
Why?
|
| Collagen | 3 | 2020 | 2618 | 0.060 |
Why?
|
| Databases, Bibliographic | 1 | 2005 | 128 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 3110 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2009 | 1070 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 2207 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2009 | 618 | 0.060 |
Why?
|
| Energy Intake | 1 | 2012 | 2141 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2024 | 3159 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2008 | 407 | 0.060 |
Why?
|
| Mucin-1 | 1 | 2009 | 531 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 1998 | 0.060 |
Why?
|
| Organoids | 2 | 2024 | 739 | 0.060 |
Why?
|
| Urine | 1 | 2005 | 360 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 2009 | 581 | 0.060 |
Why?
|
| Photochemotherapy | 2 | 2009 | 825 | 0.060 |
Why?
|
| Mice, Transgenic | 5 | 2017 | 9548 | 0.060 |
Why?
|
| Pneumonia | 1 | 2015 | 2156 | 0.060 |
Why?
|
| Proportional Hazards Models | 6 | 2016 | 12509 | 0.060 |
Why?
|
| Proteins | 2 | 2023 | 5996 | 0.050 |
Why?
|
| Hemangioma | 1 | 2009 | 723 | 0.050 |
Why?
|
| ras Proteins | 3 | 2014 | 1053 | 0.050 |
Why?
|
| Contrast Media | 6 | 2013 | 5326 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 1103 | 0.050 |
Why?
|
| Arylsulfotransferase | 1 | 2023 | 28 | 0.050 |
Why?
|
| Melanoma | 1 | 2022 | 5690 | 0.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2011 | 1376 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2007 | 1589 | 0.050 |
Why?
|
| Endoderm | 1 | 2024 | 165 | 0.050 |
Why?
|
| Mesothelioma | 1 | 2009 | 771 | 0.050 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2002 | 16 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2016 | 789 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3101 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2024 | 4642 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 1837 | 0.050 |
Why?
|
| Photosensitizing Agents | 1 | 2007 | 625 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3224 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2020 | 54795 | 0.050 |
Why?
|
| Observer Variation | 3 | 2017 | 2611 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2019 | 4520 | 0.050 |
Why?
|
| Sulfotransferases | 1 | 2023 | 151 | 0.050 |
Why?
|
| Integrin alpha2 | 1 | 2022 | 38 | 0.050 |
Why?
|
| Gadolinium | 3 | 2002 | 965 | 0.050 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 15883 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2019 | 14445 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2003 | 210 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2015 | 2350 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4352 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2023 | 1892 | 0.050 |
Why?
|
| Leukocyte Count | 2 | 2016 | 1602 | 0.050 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2021 | 46 | 0.050 |
Why?
|
| Life Cycle Stages | 1 | 2022 | 161 | 0.050 |
Why?
|
| Transfection | 2 | 2019 | 5744 | 0.050 |
Why?
|
| Time Factors | 7 | 2021 | 40066 | 0.050 |
Why?
|
| Ischemia | 1 | 2010 | 1910 | 0.050 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 2011 | 0.050 |
Why?
|
| Exons | 2 | 2019 | 2391 | 0.040 |
Why?
|
| Lamivudine | 1 | 2022 | 368 | 0.040 |
Why?
|
| Neoplasm Metastasis | 3 | 2017 | 4885 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2013 | 5125 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2019 | 8279 | 0.040 |
Why?
|
| Colon, Sigmoid | 1 | 2001 | 124 | 0.040 |
Why?
|
| Genes, MHC Class I | 1 | 2021 | 236 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2002 | 460 | 0.040 |
Why?
|
| Cell Movement | 3 | 2018 | 5192 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2019 | 15 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 3605 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2546 | 0.040 |
Why?
|
| ROC Curve | 3 | 2016 | 3618 | 0.040 |
Why?
|
| Papillomaviridae | 2 | 2016 | 1137 | 0.040 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2019 | 71 | 0.040 |
Why?
|
| Nomograms | 1 | 2021 | 235 | 0.040 |
Why?
|
| DNA Polymerase II | 1 | 2020 | 104 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2022 | 855 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2019 | 193 | 0.040 |
Why?
|
| Muscle Cells | 1 | 2020 | 194 | 0.040 |
Why?
|
| Florida | 1 | 2020 | 416 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2019 | 113 | 0.040 |
Why?
|
| Massachusetts | 4 | 2019 | 8876 | 0.040 |
Why?
|
| Aging | 1 | 2018 | 8730 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 1807 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4961 | 0.040 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2019 | 99 | 0.040 |
Why?
|
| Carcinoma, Lobular | 1 | 2003 | 470 | 0.040 |
Why?
|
| Intestinal Perforation | 1 | 2001 | 253 | 0.040 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 323 | 0.040 |
Why?
|
| Mucin 5AC | 2 | 2009 | 96 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2008 | 1349 | 0.040 |
Why?
|
| Molecular Probes | 1 | 2020 | 307 | 0.040 |
Why?
|
| Incidence | 4 | 2019 | 21478 | 0.040 |
Why?
|
| Mycobacterium leprae | 1 | 1998 | 95 | 0.040 |
Why?
|
| Heart Failure | 1 | 2003 | 11840 | 0.040 |
Why?
|
| Proto-Oncogenes | 1 | 2019 | 320 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2000 | 640 | 0.040 |
Why?
|
| Antigens, CD | 3 | 2014 | 4020 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2019 | 237 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2002 | 550 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 882 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2019 | 2573 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 3419 | 0.040 |
Why?
|
| Uncertainty | 1 | 2022 | 761 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 784 | 0.040 |
Why?
|
| Ileum | 1 | 2020 | 558 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14745 | 0.040 |
Why?
|
| Peripheral Nervous System | 1 | 1998 | 151 | 0.040 |
Why?
|
| Transcription Factor TFIIIA | 1 | 2016 | 24 | 0.030 |
Why?
|
| Kidney | 2 | 2016 | 7066 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 2018 | 276 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2015 | 5879 | 0.030 |
Why?
|
| RNA Probes | 1 | 2016 | 110 | 0.030 |
Why?
|
| Hematoxylin | 1 | 2016 | 61 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2005 | 3633 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2016 | 109 | 0.030 |
Why?
|
| Neutrophils | 1 | 2009 | 3772 | 0.030 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2016 | 70 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 798 | 0.030 |
Why?
|
| PPAR delta | 1 | 2016 | 40 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2012 | 1775 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2019 | 371 | 0.030 |
Why?
|
| Neprilysin | 2 | 2009 | 484 | 0.030 |
Why?
|
| Genome, Human | 1 | 2009 | 4446 | 0.030 |
Why?
|
| Cell Division | 2 | 2014 | 4472 | 0.030 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2003 | 1082 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2016 | 6307 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 5787 | 0.030 |
Why?
|
| Tumor Burden | 2 | 2012 | 1884 | 0.030 |
Why?
|
| Genes, APC | 1 | 2016 | 144 | 0.030 |
Why?
|
| U937 Cells | 1 | 2015 | 259 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 1770 | 0.030 |
Why?
|
| Neoplasm, Residual | 2 | 2012 | 1009 | 0.030 |
Why?
|
| International Cooperation | 2 | 2012 | 1432 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2001 | 1602 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2016 | 765 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 1024 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 2017 | 408 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 569 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 7599 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2020 | 801 | 0.030 |
Why?
|
| Mucin-4 | 1 | 2014 | 33 | 0.030 |
Why?
|
| Silver Compounds | 1 | 2014 | 24 | 0.030 |
Why?
|
| Osteonectin | 1 | 2014 | 33 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2000 | 1393 | 0.030 |
Why?
|
| Dyspnea | 1 | 2003 | 1352 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 1998 | 703 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 685 | 0.030 |
Why?
|
| Nasal Septum | 1 | 2016 | 130 | 0.030 |
Why?
|
| Quantum Theory | 1 | 2014 | 69 | 0.030 |
Why?
|
| Retinal Dehydrogenase | 1 | 2014 | 78 | 0.030 |
Why?
|
| Spiral Cone-Beam Computed Tomography | 1 | 2015 | 32 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 1385 | 0.030 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 48 | 0.030 |
Why?
|
| Antibody Diversity | 1 | 2014 | 71 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2019 | 723 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 778 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2019 | 1240 | 0.030 |
Why?
|
| Algorithms | 2 | 2012 | 14061 | 0.030 |
Why?
|
| Receptors, CXCR | 1 | 2014 | 52 | 0.030 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2014 | 142 | 0.030 |
Why?
|
| CA-19-9 Antigen | 1 | 2014 | 109 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1107 | 0.030 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2014 | 102 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 431 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2014 | 403 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2016 | 627 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2020 | 3067 | 0.030 |
Why?
|
| Telomerase | 1 | 2019 | 749 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3054 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2017 | 962 | 0.030 |
Why?
|
| Maxillary Diseases | 1 | 2013 | 46 | 0.030 |
Why?
|
| Molecular Imaging | 1 | 2020 | 822 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1056 | 0.030 |
Why?
|
| Proton Pumps | 1 | 2013 | 29 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 12800 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 1154 | 0.030 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2015 | 257 | 0.030 |
Why?
|
| Autoantibodies | 2 | 2013 | 2112 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2014 | 252 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2014 | 430 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2019 | 18972 | 0.030 |
Why?
|
| Telomere | 1 | 2019 | 941 | 0.030 |
Why?
|
| Gastric Fundus | 1 | 2012 | 37 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2009 | 2845 | 0.030 |
Why?
|
| Consensus | 2 | 2014 | 3200 | 0.030 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2012 | 38 | 0.030 |
Why?
|
| Actins | 1 | 2020 | 2056 | 0.030 |
Why?
|
| DNA Replication | 1 | 2020 | 1432 | 0.030 |
Why?
|
| Cardia | 1 | 2012 | 61 | 0.030 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2012 | 17 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2014 | 268 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2022 | 1543 | 0.030 |
Why?
|
| Gene Expression | 2 | 2019 | 7584 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2012 | 6869 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 321 | 0.030 |
Why?
|
| Chloride Channels | 1 | 2014 | 221 | 0.030 |
Why?
|
| Propensity Score | 1 | 2020 | 1968 | 0.020 |
Why?
|
| Prostate | 1 | 2020 | 1752 | 0.020 |
Why?
|
| Registries | 2 | 2019 | 8293 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2001 | 4858 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2013 | 623 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 720 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2218 | 0.020 |
Why?
|
| Cytokines | 2 | 2018 | 7424 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 367 | 0.020 |
Why?
|
| Surface Properties | 1 | 2014 | 1152 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2016 | 904 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2019 | 2666 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2016 | 1718 | 0.020 |
Why?
|
| Prolapse | 1 | 2011 | 63 | 0.020 |
Why?
|
| Morpholines | 1 | 2014 | 577 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 4850 | 0.020 |
Why?
|
| Serologic Tests | 1 | 2013 | 382 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2013 | 561 | 0.020 |
Why?
|
| Pressure | 1 | 2014 | 1169 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12056 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 1029 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2014 | 576 | 0.020 |
Why?
|
| Workflow | 1 | 2015 | 861 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2012 | 277 | 0.020 |
Why?
|
| Exophthalmos | 1 | 2011 | 99 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2012 | 472 | 0.020 |
Why?
|
| Clone Cells | 1 | 2014 | 1672 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2014 | 1749 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 2045 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2016 | 1078 | 0.020 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2012 | 248 | 0.020 |
Why?
|
| Graft Survival | 1 | 2001 | 3890 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 723 | 0.020 |
Why?
|
| Autoantigens | 1 | 2014 | 883 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2012 | 304 | 0.020 |
Why?
|
| Oxygen | 1 | 2001 | 4242 | 0.020 |
Why?
|
| Coronary Disease | 2 | 2001 | 5911 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 1027 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2019 | 2850 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2022 | 3052 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 1481 | 0.020 |
Why?
|
| Awareness | 1 | 2014 | 653 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1461 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2011 | 222 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2001 | 4494 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2014 | 864 | 0.020 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2010 | 169 | 0.020 |
Why?
|
| Syndecan-1 | 1 | 2010 | 163 | 0.020 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2000 | 1644 | 0.020 |
Why?
|
| Cyclic S-Oxides | 1 | 2009 | 23 | 0.020 |
Why?
|
| Amino Acids | 1 | 2015 | 1709 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 22321 | 0.020 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2008 | 52 | 0.020 |
Why?
|
| Calcinosis | 2 | 2013 | 1477 | 0.020 |
Why?
|
| Age Factors | 2 | 2016 | 18375 | 0.020 |
Why?
|
| Oral Surgical Procedures | 1 | 2010 | 172 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2010 | 386 | 0.020 |
Why?
|
| Thiadiazoles | 1 | 2009 | 64 | 0.020 |
Why?
|
| Mucin-6 | 1 | 2008 | 15 | 0.020 |
Why?
|
| Glucagonoma | 1 | 2008 | 14 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2393 | 0.020 |
Why?
|
| Common Bile Duct | 1 | 2008 | 106 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2016 | 1728 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 1663 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2016 | 1783 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2011 | 294 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2008 | 50 | 0.020 |
Why?
|
| Iopamidol | 1 | 2008 | 188 | 0.020 |
Why?
|
| Myocardium | 1 | 2001 | 4763 | 0.020 |
Why?
|
| Quinazolines | 1 | 2014 | 1365 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2012 | 3359 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 5747 | 0.020 |
Why?
|
| Pregnancy | 2 | 2020 | 30248 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 1964 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 1669 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2010 | 429 | 0.020 |
Why?
|
| Metaplasia | 1 | 2008 | 326 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2657 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2012 | 2229 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 6109 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2007 | 348 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1511 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2425 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3485 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2009 | 822 | 0.020 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2006 | 64 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2012 | 933 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1108 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2828 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 1059 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 1242 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2007 | 453 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 3431 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2215 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1544 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1743 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2012 | 2864 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2009 | 1639 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2020 | 8062 | 0.010 |
Why?
|
| Orofaciodigital Syndromes | 1 | 1984 | 21 | 0.010 |
Why?
|
| Swine | 1 | 2014 | 5986 | 0.010 |
Why?
|
| Ectromelia | 1 | 1984 | 28 | 0.010 |
Why?
|
| Longevity | 1 | 2012 | 1087 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2011 | 3614 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2891 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 6219 | 0.010 |
Why?
|
| Syndrome | 1 | 2010 | 3268 | 0.010 |
Why?
|
| Glutens | 1 | 2006 | 240 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2006 | 520 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12402 | 0.010 |
Why?
|
| Mitochondria | 1 | 2017 | 3670 | 0.010 |
Why?
|
| Regeneration | 1 | 2012 | 1517 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2056 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2010 | 1489 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5501 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2011 | 1883 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2008 | 2263 | 0.010 |
Why?
|
| Hypertension | 1 | 2003 | 8626 | 0.010 |
Why?
|
| Hospitals, General | 1 | 2007 | 802 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9299 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5781 | 0.010 |
Why?
|
| Age Distribution | 1 | 2008 | 2859 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2012 | 2589 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2003 | 568 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2746 | 0.010 |
Why?
|
| Models, Biological | 1 | 2018 | 9441 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8732 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2014 | 4912 | 0.010 |
Why?
|
| Ultrasonography, Mammary | 1 | 2003 | 241 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2009 | 1531 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 1884 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2019 | 26332 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5019 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
| Cytogenetic Analysis | 1 | 2000 | 269 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3926 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 16041 | 0.010 |
Why?
|
| Epilepsy | 1 | 2015 | 3318 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 4057 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2006 | 737 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2008 | 3559 | 0.010 |
Why?
|
| Sex Factors | 1 | 2012 | 10605 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2001 | 1478 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 2002 | 872 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 1880 | 0.010 |
Why?
|
| Skin | 1 | 2011 | 4474 | 0.010 |
Why?
|
| Length of Stay | 1 | 2011 | 6487 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1984 | 1424 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10730 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 3822 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 21053 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 11888 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 15542 | 0.010 |
Why?
|
| Obesity | 1 | 2016 | 13079 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2001 | 2475 | 0.010 |
Why?
|
| Mammography | 1 | 2003 | 2423 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2001 | 2554 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 11080 | 0.000 |
Why?
|
| Electrocardiography | 1 | 2001 | 6401 | 0.000 |
Why?
|
| Genes, Recessive | 1 | 1984 | 624 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1984 | 498 | 0.000 |
Why?
|
| India | 1 | 1984 | 2340 | 0.000 |
Why?
|